COSCIENS Biopharma (CSCI)
NASDAQ:CSCI
Holding CSCI?
Track your performance easily

COSCIENS Biopharma (CSCI) Financial Statements

905 Followers

COSCIENS Biopharma Financial Overview

COSCIENS Biopharma's market cap is currently ―. The company's EPS TTM is $-27.649; its P/E ratio is -0.12; COSCIENS Biopharma is scheduled to report earnings on April 1, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 2.34M$ 4.00K$ 121.00K$ 3.00K$ 1.39M
Gross Profit$ 819.00K$ -12.00K$ 288.00K$ -8.00K$ 797.00K
EBIT$ -1.87M$ -5.75M$ -5.64M$ -4.14M$ -1.07M
EBITDA$ -1.50M$ -5.70M$ -5.77M$ -4.10M$ -709.00K
Net Income Common Stockholders$ -1.42M$ -5.75M$ -5.63M$ -4.14M$ -860.00K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 27.80M$ 29.55M$ 34.02M$ 38.76M$ 42.19M
Total Assets$ 50.05M$ 31.79M$ 37.02M$ 42.49M$ 46.48M
Total Debt$ 1.69M$ 234.00K$ 279.00K$ 217.00K$ 230.00K
Net Debt$ -26.12M$ -29.31M$ -33.74M$ -38.54M$ -41.96M
Total Liabilities$ 23.82M$ 18.82M$ 18.82M$ 16.21M$ 17.40M
Stockholders Equity$ 26.23M$ 12.97M$ 18.20M$ 26.28M$ 29.08M
Cash Flow-
Free Cash Flow$ -1.55M$ -4.42M$ -6.03M$ -3.39M$ -867.00K
Operating Cash Flow$ -1.39M$ -4.42M$ -6.03M$ -3.38M$ -813.00K
Investing Cash Flow$ 25.88M$ -5.00K$ 543.00K$ -10.00K$ -54.00K
Financing Cash Flow$ -126.00K$ -42.00K$ -38.00K$ -33.00K$ -70.00K
Currency in USD

COSCIENS Biopharma Earnings and Revenue History

COSCIENS Biopharma Debt to Assets

COSCIENS Biopharma Cash Flow

COSCIENS Biopharma Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis